Skye Bioscience, Inc. SKYE
1.32 USD +0.04 +3.13%
At close · Nov 2
1.32 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
- YTD
- -78.00%
- 1 year
- -89.35%
- Open
- 1.28
- Prev close
- 1.28
- Mkt cap
- 5.84M
- Vol
- 9.69K
- Avg vol
- 90.73K
- EPS
- -10.16
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.28
- High
- 1.36
- Forward P/E
- -2.27
- Beta
- 1.75
- Short ratio
- 10.06
- Inst. own
- 86.03%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 29, 2024
- 50-d avg
- 4.44
- 200-d avg
- 7.74
- 1y target
- 18.00
5D chart
Chart tools
Chart is warming up
The five-day price history for SKYE has not been loaded yet. Try again in a moment.
Altman Z-Score
-41.52 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 4
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
P/E -0.5×
P/S 0.0×
P/B 1.5×
P/FCF -0.7×
EV/EBITDA -0.4×
EV/Sales 0.0×
FCF Yield -144.8%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -279.3%
ROIC -286.6%
ROA -197.5%
Revenue 0.0%
Operating Income -92.6%
EPS (diluted) -93.2%
Free Cash Flow -60.5%
Current Ratio 3.3×
Quick Ratio 3.3×
Debt / Equity 0.0×
Net Debt / EBITDA 0.1×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31